Vanguard Group Inc - Jun 30, 2025 SCHEDULE 13G/A Report for Bridgebio Pharma Inc Common Stock (BBIO)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Bridgebio Pharma Inc Common Stock
Symbol: BBIO
Shares outstanding: 190M shares
Disclosed Ownership: 16.5M shares
Ownership: 8.68%
Form type: SCHEDULE 13G/A
Date filed: 7/29/2025, 11:20 AM
Date of event: Jun 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	8.68%	16.5M	0	186K	Ashley Grim	Head of Global Fund Administration